Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.
- Published In:
- British journal of pharmacology, 175(1), 3-17 (2018)
- Authors:
- Hay, Debbie L(5), Garelja, Michael L, Poyner, David R, Walker, Christopher S
- Database ID:
- RPEP-03703
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03703APA
Hay, Debbie L; Garelja, Michael L; Poyner, David R; Walker, Christopher S. (2018). Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.. British journal of pharmacology, 175(1), 3-17. https://doi.org/10.1111/bph.14075
MLA
Hay, Debbie L, et al. "Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25.." British journal of pharmacology, 2018. https://doi.org/10.1111/bph.14075
RethinkPeptides
RethinkPeptides Research Database. "Update on the pharmacology of calcitonin/CGRP family of pept..." RPEP-03703. Retrieved from https://rethinkpeptides.com/research/hay-2018-update-on-the-pharmacology
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.